-
Paclitaxel (Taxol) in the Era of Tumor Microenvironment C...
2025-10-24
This thought-leadership article explores how Paclitaxel (Taxol), a gold-standard microtubule polymer stabilizer, is being reimagined for advanced translational research at the intersection of tumor microenvironment complexity and patient-specific models. Integrating mechanistic insights, new assembloid data, and strategic guidance, we chart a path for translational researchers seeking to transcend conventional cancer models and accelerate clinical innovation.
-
Hesperadin: Precision Aurora B Kinase Inhibitor for Cell ...
2025-10-23
Hesperadin enables high-resolution dissection of mitotic progression, spindle assembly checkpoint function, and polyploidization in cancer and cell cycle research. Its ATP-competitive specificity for Aurora B kinase delivers robust inhibition of chromosome alignment and segregation, setting a new benchmark for experimental clarity and reproducibility.
-
Hesperadin: ATP-Competitive Aurora B Kinase Inhibitor for...
2025-10-22
Hesperadin stands out as a potent ATP-competitive Aurora B kinase inhibitor, enabling high-precision dissection of mitotic progression and spindle assembly checkpoint dynamics. Its robust inhibition profile and compatibility with advanced experimental workflows make it indispensable for unraveling cell cycle regulation and cancer research applications.
-
Paclitaxel (Taxol): Mechanism-Based Insights for Predicti...
2025-10-21
Explore Paclitaxel (Taxol) as a microtubule polymer stabilizer, delving into its mechanistic precision and the integration of high-content phenotypic profiling with machine learning for advanced cancer research. This article uniquely bridges MoA prediction and experimental design, setting a new benchmark for translational oncology studies.
169 records 12/12 page Previous First page 上5页 1112